Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
{{output}}
Angiogenesis is a hallmark of cancer development. This study sought to determine the recommended dose of aflibercept, a recombinant fusion protein targeting VEGF-A, VEGF-B and placental growth factor (PlGF), combined with docetaxel in Japanese patients with ad... ...
